Degradation of platelet-von Willebrand factor complexes by plasmin: an alternative/backup mechanism to ADAMTS13.
作者信息
Chauhan Anil K
机构信息
Department of Internal Medicine, University of Iowa, Iowa City, IA.
出版信息
Circulation. 2014 Mar 25;129(12):1273-5. doi: 10.1161/CIRCULATIONAHA.114.008298. Epub 2014 Jan 21.
Abstract
摘要
相似文献
1
Degradation of platelet-von Willebrand factor complexes by plasmin: an alternative/backup mechanism to ADAMTS13.
Circulation. 2014 Mar 25;129(12):1273-5. doi: 10.1161/CIRCULATIONAHA.114.008298. Epub 2014 Jan 21.
2
Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Circulation. 2014 Mar 25;129(12):1320-31. doi: 10.1161/CIRCULATIONAHA.113.006727. Epub 2014 Jan 21.
3
Response to letter regarding article, "plasmin cleavage of von willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy".
Circulation. 2015 Jan 13;131(2):e19-20. doi: 10.1161/CIRCULATIONAHA.114.012802.
4
Letter by Hugenholtz and Lisman regarding article, "plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy".
Circulation. 2015 Jan 13;131(2):e18. doi: 10.1161/CIRCULATIONAHA.114.009307.
5
Binding of von Willebrand factor cleaving protease ADAMTS13 to Lys-plasmin(ogen).
J Biochem. 2012 Sep;152(3):251-8. doi: 10.1093/jb/mvs066. Epub 2012 Jun 7.
6
Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis.
Blood. 2024 May 16;143(20):2089-2098. doi: 10.1182/blood.2023021265.
7
Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13.
Sci Rep. 2024 Apr 20;14(1):9073. doi: 10.1038/s41598-024-59672-6.
8
Proteolytic inactivation of ADAMTS13 by plasmin in human plasma: risk of thrombotic thrombocytopenic purpura.
J Biochem. 2018 May 1;163(5):381-389. doi: 10.1093/jb/mvx084.
9
Thrombotic microangiopathies: multimers, metalloprotease, and beyond.
Clin Transl Sci. 2009 Oct;2(5):366-73. doi: 10.1111/j.1752-8062.2009.00142.x.
10
Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies.
Thromb Haemost. 2011 Feb;105(2):381-5. doi: 10.1160/TH10-06-0417. Epub 2010 Nov 23.
引用本文的文献
1
Molecular Pathogenesis of Endotheliopathy and Endotheliopathic Syndromes, Leading to Inflammation and Microthrombosis, and Various Hemostatic Clinical Phenotypes Based on "Two-Activation Theory of the Endothelium" and "Two-Path Unifying Theory" of Hemostasis.
Medicina (Kaunas). 2022 Sep 19;58(9):1311. doi: 10.3390/medicina58091311.
2
Hemostasis components in cerebral amyloid angiopathy and Alzheimer's disease.
Neurol Sci. 2021 Aug;42(8):3177-3188. doi: 10.1007/s10072-021-05327-7. Epub 2021 May 27.
本文引用的文献
1
Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Circulation. 2014 Mar 25;129(12):1320-31. doi: 10.1161/CIRCULATIONAHA.113.006727. Epub 2014 Jan 21.
2
Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies.
Hematology Am Soc Hematol Educ Program. 2013;2013:292-9. doi: 10.1182/asheducation-2013.1.292.
3
Treatment of thrombotic microangiopathy with a focus on new treatment options.
Hamostaseologie. 2013 May 29;33(2):149-59. doi: 10.5482/HAMO-13-01-0004.
4
Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura.
Blood. 2012 Oct 25;120(17):3603-10. doi: 10.1182/blood-2012-04-420943. Epub 2012 Sep 4.
5
Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons.
Blood. 2012 Oct 25;120(17):3611-4. doi: 10.1182/blood-2012-04-421248. Epub 2012 Jul 31.
6
A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13.
Blood. 2012 Jun 21;119(25):6128-35. doi: 10.1182/blood-2011-09-380535. Epub 2012 Apr 23.
7
Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura.
Am J Hematol. 2012 Apr;87(4):430-2. doi: 10.1002/ajh.23106. Epub 2012 Feb 24.
8
Modulation of the von Willebrand factor-dependent platelet adhesion through alternative proteolytic pathways.
Thromb Res. 2012 Apr;129(4):e41-6. doi: 10.1016/j.thromres.2011.11.021. Epub 2011 Dec 15.
9
N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.
J Clin Invest. 2011 Feb;121(2):593-603. doi: 10.1172/JCI41062. Epub 2011 Jan 25.
10
Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site.
Blood. 2009 Aug 20;114(8):1666-74. doi: 10.1182/blood-2009-01-195461. Epub 2009 Jun 18.
Zotero 插件